Compumed Stock Performance
| CMPD Stock | USD 4.26 0.13 2.96% |
On a scale of 0 to 100, CompuMed holds a performance score of 7. The firm shows a Beta (market volatility) of -0.0773, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning CompuMed are expected to decrease at a much lower rate. During the bear market, CompuMed is likely to outperform the market. Please check CompuMed's total risk alpha, expected short fall, market facilitation index, as well as the relationship between the value at risk and daily balance of power , to make a quick decision on whether CompuMed's price patterns will revert.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in CompuMed are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, CompuMed exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
CompuMed |
CompuMed Relative Risk vs. Return Landscape
If you would invest 333.00 in CompuMed on October 19, 2025 and sell it today you would earn a total of 93.00 from holding CompuMed or generate 27.93% return on investment over 90 days. CompuMed is currently generating 0.5857% in daily expected returns and assumes 6.2848% risk (volatility on return distribution) over the 90 days horizon. In different words, 56% of pink sheets are less volatile than CompuMed, and 89% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
CompuMed Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for CompuMed's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as CompuMed, and traders can use it to determine the average amount a CompuMed's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0932
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | CMPD | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Based on monthly moving average CompuMed is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of CompuMed by adding it to a well-diversified portfolio.
CompuMed Fundamentals Growth
CompuMed Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of CompuMed, and CompuMed fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on CompuMed Pink Sheet performance.
| Return On Equity | -0.3 | |||
| Return On Asset | -0.13 | |||
| Profit Margin | (0.02) % | |||
| Operating Margin | (0.08) % | |||
| Current Valuation | 4.12 M | |||
| Shares Outstanding | 1.11 M | |||
| Price To Earning | (8.36) X | |||
| Price To Book | 36.30 X | |||
| Price To Sales | 2.43 X | |||
| Revenue | 2.31 M | |||
| EBITDA | (45 K) | |||
| Cash And Equivalents | 4 K | |||
| Total Debt | 24.91 K | |||
| Debt To Equity | 1.28 % | |||
| Book Value Per Share | 0.11 X | |||
| Cash Flow From Operations | 175.43 K | |||
| Earnings Per Share | (0.01) X | |||
| Total Asset | 835.02 K | |||
| Retained Earnings | (37.15 M) | |||
| Current Asset | 392 K | |||
| Current Liabilities | 248 K | |||
About CompuMed Performance
By analyzing CompuMed's fundamental ratios, stakeholders can gain valuable insights into CompuMed's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if CompuMed has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if CompuMed has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
CompuMed, Inc., an enterprise telemedicine solutions company, provides clinical care services for patients and medical facilities. CompuMed, Inc. was founded in 1973 and is headquartered in Los Angeles, California. Compumed operates under Health Information Services classification in the United States and is traded on OTC Exchange. It employs 8 people.Things to note about CompuMed performance evaluation
Checking the ongoing alerts about CompuMed for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for CompuMed help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| CompuMed is way too risky over 90 days horizon | |
| CompuMed appears to be risky and price may revert if volatility continues |
- Analyzing CompuMed's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether CompuMed's stock is overvalued or undervalued compared to its peers.
- Examining CompuMed's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating CompuMed's management team can have a significant impact on its success or failure. Reviewing the track record and experience of CompuMed's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of CompuMed's pink sheet. These opinions can provide insight into CompuMed's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for CompuMed Pink Sheet analysis
When running CompuMed's price analysis, check to measure CompuMed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CompuMed is operating at the current time. Most of CompuMed's value examination focuses on studying past and present price action to predict the probability of CompuMed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CompuMed's price. Additionally, you may evaluate how the addition of CompuMed to your portfolios can decrease your overall portfolio volatility.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |